CVS Pharmacy finalizes purchase of 63 Rite Aid and Bartell Drugs stores and prescription records, now serving over nine million former patients and investing in staff expansion.

CVS Caremark, the pharmacy benefit manager of CVS, is entering into a larger PBM contract with the Government-wide Service Benefit Plan, otherwise known as the Federal Employee Program. CVS Health has ...

Healthcare conglomerate CVS Health CVS formed its Health Services segment through a realignment tied to a new operating model adopted in early 2023. In its last reported quarter, the segment ...

CVS Health has named two key leaders for its pharmacy and consumer products business, including a returning face to the company. David Joyner, a former executive at the company, will make a return as ...

Woonsocket, R.I.-based CVS Health outlined five strategies the company deployed in its retail pharmacy services for a consumer-driven approach to healthcare, according to DrugStoreNews. “The ...

CVS Health’s stock falls as a large charge to write off the value of an underperforming business takes the shine off an ...

In recent days, analyst Jim Cramer highlighted CVS Health as the leading player remaining in the retail pharmacy space, ...

On Mar 19, we issued an updated research report on CVS HealthCVS. While increasing demand for PBM (Pharmacy Benefit Management) and specialty pharmacy was a major growth driver for the stock, its dull ...

Some customers who were unable to fill or pick up their prescriptions at CVS locations on Tuesday because of technical issues ...

CVS Health raised its annual adjusted profit forecast on Wednesday, aided by improved pharmacy revenues, but also announced a $5.73 billion writedown of healthcare businesses including its in-pharmacy ...

This story was updated following CVS Health's earnings call Wednesday morning. | The company reported improvements in its ...

CVS Health said profits and sales rose across all businesses in the fourth quarter of last year as the company begins 2017, a year when pharmacy benefit managers face scrutiny in the emerging drug ...